Evaluation of circulating glypican 4 as a novel biomarker in disease – A comprehensive review

Journal article

Peer reviewed

A. Muendlein, A. Leiherer and H. Drexel

Journal of molecular medicine (Berlin, Germany), v 103(4), pp 355-364

01 Apr 2025

PMID: 39961831

Additional Links

Biomarker

Cancer

Glycocalyx

Glypican 4

Insulin resistance

Kidney function

Cardiovascular Disease

1 Record Views

Title: Evaluation of circulating glypican 4 as a novel biomarker in disease – A comprehensive review
Creators: A. Muendlein - Vorarlberg Institute for Vascular Investigation and Treatment
A. Leiherer - Private University in the Principality of Liechtenstein
H. Drexel - Vorarlberg Institute for Vascular Investigation and Treatment
Publication Details: Journal of molecular medicine (Berlin, Germany), v 103(4), pp 355-364
Publisher: Springer Nature
Number of pages: 10
Resource Type: Journal article
Language: English
Academic Unit: College of Medicine
Web of Science ID: WOS:001423096100001
Scopus ID: 2-s2.0-85219690484
Other Identifier: 991022197315404721

This publication has contributed to the advancement of the following goals:

Source: SDGs in the Output

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: International collaboration
Web of Science research areas: Genetics & Heredity; Medicine, Research & Experimental